Hui Wang

8PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 03, 2026
CD72 as a complementary B-lineage marker for longitudinal measurable residual disease surveillance after CD19 CAR-T therapy in R/R B-ALL.

|Nov 19, 2024
Nanobody-based naturally selected CD7-targeted CAR-T therapy for acute myeloid leukemia.

Peihua Lu, Xian Zhang, Junfang Yang

|Jan 31, 2023
Abnormalities by Multicolor Flow Cytometry for Detection of Minimal Residual Disease in Recipients of Allo-HSCT Originating from Donors: A Cohort Study

Hui Wang, Aixian Wang, Man Chen

|Oct 21, 2021
Cytoplasmic CD79a is a promising biomarker for B lymphoblastic leukemia follow up post CD19 CAR-T therapy.

Man Chen, Minjing Fu, Aixian Wang

Pageof 2

Frequent Collaborators

4 joint publications

Man Chen

2 joint publications

Ting Li

1 joint publications

Aixian Wang

1 joint publications

Meiwei Gong